Identification and Determination of Potential Impurities Present in the Acyclovir Drug Substance by GC-MS

Author(s): Natarajan Sivanandham*, Kempegowda Bommanadoddi Kempegowda

Journal Name: Current Pharmaceutical Analysis

Volume 13 , Issue 5 , 2017


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: In the manufacturing of the Acyclovir drug substance, that there are some process solvents, which includes Benzene, Hexamethyldisilazane (HMDS) and Methylcyanoacetate, are used. These are toxic to human health. These residual solvents in the drug substance are required to have an analytical method to detect these impurities in the lowest possible level in order to ensure the human safety and drug efficacy. There is no method to determine these solvents which are specific to this drug substance.

Objective: The objective of the research work is to develop the accurate and robust analytical method to determine the toxic impurities present in the Acyclovir drug substance to the lowest possible level.

Method: The method uses the GC-MS in order to determine the impurities in the lowest possible detection level.

Result: The method was taken for critical analytical method validation parameters and observed that specificity, linearity and LOQ were found satisfactory. The LOQ of the Hexamethyl disilazane (0.0042mg/ml), Benzene (0.0003mg/ml) and Methylcyanoacetate (0.0001mg/ml).

Conclusion: The method shall be applied for Toxic/GIs of HMDS, Benzene and Methylcyanoacete present in the Acyclovir drug substance. This method shall also be applied for other APIs by optimizing the instrument parameters and sample preparations.

Keywords: Acyclovir, toxic impurities, GC-MS method, drug substance, residual solvents, API.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 5
Year: 2017
Published on: 07 August, 2017
Page: [473 - 480]
Pages: 8
DOI: 10.2174/1573412913666170321110612
Price: $65

Article Metrics

PDF: 16
HTML: 1